Aragon Investors Step Up for Seragon’s $30M Series A
Seragon Pharmaceuticals Inc. didn’t have to look very far to find investors for its $30 million Series A round.
The San Diego-based firm, which was spun out from Aragon Pharmaceuticals Inc. just prior to Aragon’s August acquisition by Johnson & Johnson, brought on board Aragon’s investors Venbio, Topspin Fund, Aisling Capital, OrbiMed Advisors and the Column Group. All had participated in Aragon’s $50 million Series D round last year. (See BioWorld Today, Oct. 5, 2012.)
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST